Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Asthma mucus study pulled before it began

NCT ID NCT04514913

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study planned to use a special camera (virtual navigation bronchoscopy) to collect samples from mucus plugs in the lungs of people with asthma. The goal was to compare inflammation markers between plugged and non-plugged airways, and with healthy volunteers. However, the study was withdrawn before enrolling anyone, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Expected to start

Feb 2023

An estimate. Start dates often move.

Finished

Feb 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with asthma who present with or without mucus plugs, as well as healthy controls, all between the ages of 18 and 70.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Group 1: Healthy Controls Inclusion Criteria: * Male or female between the ages of 18 and 70 years at Visit 1 and at least 50% whose age is \> 40 years (to ensure age balance among groups and anticipating that group 3 subjects will be older). * Written informed consent obtained from subject and ability for subject to comply with the requirements of the study. * Able to perform reproducible spirometry according to ATS criteria. Exclusion Criteria: * Upper respiratory tract infection (URI) within the previous 6 weeks. * History of lung disease. * Smoking of tobacco or other recreational inhalants in last month and/or \>10 pack-year smoking history. * Currently pregnant. * History of allergic rhinitis. * Laboratory evidence of atopy (blood eosinophils \> 0.4 cells/dL, IgE \> 165 IU/mL) * History of unstable cardiovascular disease. * BMI \> 45 * Currently taking anticoagulants. Group 2: Asthmatic Subjects without Mucus Plugs Inclusion Criteria: * Male or female between the ages of 18 and 70 years at Visit 1 and at least 50% whose age is \> 40 years (to ensure age balance among groups and anticipating that group 3 subjects will be older). * Written informed consent obtained from subject and ability for subject to comply with the requirements of the study. * Able to perform reproducible spirometry according to ATS criteria. * Physiological evidence of airflow obstruction (FEV1 bronchodilator reversibility of ≥ 12% or hyperreactivity to methacholine reflected by a methacholine PC20 ≤ 16 mg/mL). Historical methacholine data from previous studies conducted in the past 5 years at the UCSF ACRC will be allowed. * Clinical history of asthma per patient report or medical record. * Asthma requiring treatment with inhaled corticosteroids (ICS) for 3 months or greater. Exclusion Criteria: * Asthma exacerbation or URI within the previous 6 weeks. * Currently pregnant. * Smoking of tobacco or other recreational inhalants in last month and/or \>10 pack-year smoking history. * Other chronic pulmonary disorders, including cystic fibrosis and chronic obstructive pulmonary disease. * History of unstable cardiovascular disease. * BMI \> 45. * Currently taking anticoagulants. Group 3: Asthmatic Subjects with Mucus Plugs Inclusion: * Male or female between the ages of 18 and 70 years at Visit 1. * Written informed consent obtained from subject and ability for subject to comply with the requirements of the study. * Able to perform reproducible spirometry according to ATS criteria. * Physiological evidence of airflow obstruction (FEV1 bronchodilator reversibility of ≥ 12% or hyperreactivity to methacholine reflected by a methacholine PC20 ≤ 16 mg/mL). Historical methacholine data from previous studies conducted in the past 5 years at the UCSF ACRC will be allowed. * Clinical history of asthma per patient report or medical record. * Asthma requiring treatment with inhaled corticosteroids (ICS) for 3 months or greater. * A MDCT lung scan indicating a mucus plug accessible by bronchoscopy in at least one airway. Exclusion Criteria: * Asthma exacerbation or URI within the previous 6 weeks. * Currently pregnant. * Smoking of tobacco or other recreational inhalants in last month and/or \>10 pack-year smoking history. * Other chronic pulmonary disorders, including cystic fibrosis and chronic obstructive pulmonary disease. * History of unstable cardiovascular disease. * BMI \> 45. * Currently taking anticoagulants. * Mucus plugs inaccessible by bronchoscope.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UCSF Airway Clinical Research Center

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.